Vanier MT .2013 .Niemann-pick diseases. The Handbook of Clinical Neurology, 113 : 1717-1721.
Kolodny EH .2000 .Niemann-Pick disease. Current Opinion in Hematology, 7(1) : 48-52.
Percival BC,Gibson M,Wilson PB,Platt FM,Grootveld M. .2020 .Metabolomic studies of lipid storage disorders, with special reference to Niemann-Pick type C disease: A critical review with future perspectives. International Journal of Molecular Sciences, 21(7) : 2533.
Rodrigues KF,Yong WTL,Bhuiyan MSA,Siddiquee S,Shah MD .2022 .Current understanding on the genetic basis of key metabolic disorders: a review. Biology, 11(9) : 1308.
Vitiello L,De Bernardo M,Nuzio SG,Mandato C,Rosa N,Vajro P .2020 .Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other. Digestive and liver disease, 52(1) : 1-8.
Toledano-Zaragoza A,Ledesma MD .2020 .Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases. , 171 : 107851.
Schuchman EH,Desnick RJ .2017 .Types a and B Niemann-pick disease. Molecular Genetics and Metabolism, 120(1- 2) : 27-33.
Pfrieger FW .2023 .The Niemann-Pick type diseases-A synopsis of inborn errors in sphingolipid and cholesterol metabolism. Progress in Lipid Research, 90 : 101225.
Vanier .2010 .. Orphanet Journal of Rare Diseases, : 1-18.
Guatibonza Moreno P,Pardo LM,Pereira C,Schroeder S,Vagiri D .2023 .At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years. European Journal of Human Genetics, 31(10) : 1108-1116.
Hendriksz CJ,Anheim M,Bauer P,Bonnot O,Chakrapani A .2017 .The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Current Medical Research and Opinion, 33(5) : 877-890.
Patterson M.,Niemann-Pick disease M. .2020 .. , : 1993-2024.
McGovern MM,Avetisyan R,Sanson B-J .2017 .Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Current Medical Research and Opinion, 12(1) : 1-13.
Pinto C,Sousa D,Ghilas V,Dardis A,Scarpa M .2021 .and Macedo MF Acid sphingomyelinase deficiency: a clinical and immunological perspective. International Journal of Molecular Sciences, 22(23) : 12870.
Zampieri S,Filocamo M,Pianta A,Lualdi S,Gort L,Coll MJ,Sinnott R,Geberhiwot T,Bembi B,Dardis A .2016 .SMPD1 mutation update: database and comprehensive analysis of published and novel variants. Human Mutation, 37(2) : 139-147.
Deshpande D,Gupta SK,Sarma AS,Ranganath P,Jain S JMN .2021 .Functional characterization of novel variants in SMPD1 in Indian patients with acid sphingomyelinase deficiency. Human Mutation, 42(10) : 1336-1350.
. .Infantile spasms in early-onset Niemann-Pick disease with a novel compound heterozygous mutations in SMPD1 gene. , : .
Elsevier .2015 .. , 2(6) : 155-158.
Mukherjee SB,Pandey M,Kapoor S .2012 .Infant with type A Niemann Pick disease and undetectable Niemann Pick cells in bone marrow. Indian Pediatrics, 49(6) : 490.
Reddy JV,Ganley IG .2006 .Clues to neurodegeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One, 1(1) : e19.
.2021 .. International Journal of Molecular Sciences, 22(16) : 8858.
Bulut FD,Bozbulut NE,Özalp Ö,Dalgiç B,Mungan NÖ .2022 .Diagnostic value of plasma lysosphingolipids levels in a Niemann-Pick disease type C patient with transient neonatal cholestasis. Journal of Pediatric Endocrinology and Metabolism, 35(5) : 681-685.
Newton J,Palladino EN,Weigel C,Maceyka M,Gräler MH .2020 .Targeting defective sphingosine kinase 1 in NiemannPick type C disease with an activator mitigates cholesterol accumulation. Journal of Biological Chemistry, 295(27) : 9121-9133.
.2023 .Childhood dementia: A collective clinical approach to advance therapeutic development and care. Pediatric Neurology, 139 : 76-85.
Cariati I,Masuelli L,Bei R,Tancredi V,Frank C,D'Arcangelo G. .2021 .Neurodegeneration in niemann-pick type c disease: An updated review on pharmacological and nonpharmacological approaches to counteract brain and cognitive impairment. International Journal of Molecular Sciences, 22(12) : 6600.
Marchetti M,Faggiano S .2022 .Mozzarelli A. Enzyme replacement therapy for genetic disorders associated with enzyme deficiency. Current Medicinal Chemistry, 29(3) : 489-525.
Garside B,Ho JH,Kwok S,Liu Y,Dhage S . .Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfa. , : .
.2021 .. Orphanet Journal of Rare Diseases, 27(1) : 107.
Ryckman AE,Brockhausen I .2020 .Walia, JS. Metabolism of glycosphingolipids and their role in the pathophysiology of lysosomal storage disorders. nternational Journal of Molecular Sciences, 21(18) : 6881.
Zakir F,Mohapatra S,Farooq U,Mirza MA,Iqbal Z .2022 .. Drug Delivery Systems for Metabolic Disorders, : 1-20.
.2023 .Childhood dementia: A collective clinical approach to advance therapeutic development and care. Pediatric Neurology, 139 : 76-85.
Kannan P,Nanda Kumar MP,Rathinam N,Kumar DT,Ramasamy M. Elucidating .2023 .the mutational impact in causing Niemann-Pick disease type C: an in silico approach. Journal of Biomolecular Structure and Dynamics, 41(17) : 8561-8570.
Dardis A,Zampieri S,Gellera C,Carrozzo R,Cattarossi S .2020 .Molecular genetics of Niemann-Pick Type C disease in Italy: an update on 105 patients and description of 18 NPC1 novel variants. Journal of Clinical Medicine, 9(3) : 679.
Xu Y,Zhang Q,Tan L,Xie X,Zhao Y. .2019 .The characteristics and biological significance of NPC2: Mutation and disease. Mutation Research - Reviews in Mutation Research, 782 : 108284.
Metcalfe SA .2018 .Genetic counselling, patient education, and informed decision-making in the genomic era. Seminars in Fetal and Neonatal Medicine, 23(2) : 142-149.
Kumar K,Cowley M,Wetterstrand K,Watson J,Crick F,Sanger F,Nicklen S .2019 .Next-generation sequencing and emerging technologies. in Seminars in thrombosis and hemostasis. , : .
Sudrié-Arnaud B,Snanoudj S,Dabaj I,Dranguet H,AbilyDonval L H .2021 .Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel. , 11(2) : 294.
Guan C,Gan X,Yang C,Yi M,Zhang Y .2022 .Wholeexome sequencing analysis to identify novel potential pathogenetic NPC1 mutations in two Chinese families with Niemann-Pick disease type C. Neurological Sciences, (. , 43(6) : 3957-3966.
Brain Metabolic,Disease Metabolic .2019 .. , 34(5) : 1253-1260.
Hu J,Maegawa GH,Zhan X,Gao X,Wang Y .2021 .Clinical, biochemical, and genotype‐phenotype correlations of 118 patients with Niemann‐Pick disease Types A/B. , 42(5) : 614-625.
Cooper J,Church H,Wu HY .2020 .-triol: further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C. Molecular Genetics and Metabolism, (. , 130(1) : 77-86.
.2023 .Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study. Journal of Neuroradiology, 44(7) : 768-775.
.2019 .Proteomics of the corpus callosum to identify novel factors involved in hypomyelinated Niemann-Pick Type C disease mice. Molecular Brain, 12(1) : 1-11.
Amin MM .2019 .(. IGI Global, : 195-216.
.2020 .Clinical and preclinical imaging of hepatosplenic schistosomiasis. , 36(2) : 206-226.
Neurology Current .2020 .. , 20(11) : 51.
Genes .1990 .. , 14(11) : .
.2022 .Genetic disease and Niemann-Pick disorders: novel treatments and drug delivery systems. Drug Delivery Systems for Metabolic Disorders, : 161-175.
Pineda M,Walterfang M,Patterson MC .2018 .Miglustat in Niemann-Pick disease type C patients: a review. Orphanet Journal of Rare Diseases, 13(1) : 1-21.
Bonnot O,Klünemann H-H,Velten C,Martin JVT,Walterfang M. .2019 .Systematic review of psychiatric signs in Niemann-Pick disease type C. The World Journal of Biological Psychiatry, 20(4) : 320-332.
Rego T,Farrand S,Goh AM,Eratne D,Kelso W .2019 .Psychiatric and cognitive symptoms associated with Niemann-Pick type C disease: neurobiology and management. CNS Drugs, 33(2) : 125-142.
Li M. .2018 .Enzyme replacement therapy: a review and its role in treating lysosomal storage diseases. Pediatric Annals, 47(5) : e191-e197.
Marchetti M,Faggiano S .2022 .Mozzarelli A. Enzyme replacement therapy for genetic disorders associated with enzyme deficiency. Current Medicinal Chemistry, 29(3) : 489-525.
Jones SA,McGovern M,Lidove O,Giugliani R,Mistry PK .2020 .Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy. Molecular Genetics and Metabolism, 131(1-2) : 116-123.
Del Grosso A,Parlanti G,Mezzena R,Cecchini M. .2022 .Current treatment options and novel nanotechnologydriven enzyme replacement strategies for lysosomal storage disorders. Advanced Drug Delivery Reviews, : 114464.
Yue WW,Mackinnon S .2019 .Substrate reduction therapy for inborn errors of metabolism. Emerging Topics in Life Sciences, 3(1) : 63-73.
Höller A,Albrecht U,Sigl SB,Zöggeler T,Ramoser G .2021 .Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C. Molecular genetics and metabolism reports. , 27 : 100723.
Samaranch L,Pérez-Cañamás A,Soto-Huelin B,Sudhakar V,Jurado-Arjona J,Science Translational Medicine .2019 .Adeno-associated viral vector serotype 9-based gene therapy for NiemannPick disease type A. , 11(506) : eaat3738.
Massaro G,Geard AF,Liu W,Coombe-Tennant O,Waddington SN,Baruteau J,Gissen P,Rahim AA .2021 .Gene therapy for lysosomal storage disorders: ongoing studies and clinical development. Biomolecules, 11(4) : 611.
Jiang D,Lee H .2020 .Pardridge WM. Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes. Scientific Reports, 10(1) : 13334.
Tran ML,Génisson Y,Ballereau S .2020 .Second-generation pharmacological chaperones: beyond inhibitors. Molecules, 25(14) : 3145.
Du J,Liu X,Zhang Y,Han X,Ma C .2022 .The Effects of Combined Therapy With Metformin and Hydroxypropyl-β- Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1. , 12 : 825425.
Holzmann C,Witt M,Rolfs A,Antipova V .2021 .Wree A. Gender-specific effects of two treatment strategies in a mouse model of niemann-pick disease type c1. International Journal of Molecular Sciences, 22(5) : 2539.
Kurokawa Y,Osaka H,Kouga T,Jimbo E,Muramatsu K .2021 .Gene therapy in a mouse model of niemann-pick disease type C1. Human Gene Therapy, (. , 32 : 589-598.
Deodato F,Boenzi S,Taurisano R,Semeraro M,Sacchetti E .2018 .The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency. Clinica Chimica Acta, 486 : 387-394.
Jiang X,Ory D. X .2021 .Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery. Exploration of Neuroprotective Therapy, 1(3) : 146.
Sobrido M-J P,De Koning T,Klopstock T,Nadjar Y,Patterson MC,Synofzik M,Hendriksz CJ .2019 .Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C? Orphanet Journal of Rare Diseases, (. , 14(1) : 1-14.
Mengel E,Bembi B,Del Toro M,Deodato F,Gautschi M .2020 .Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study. Orphanet Journal of Rare Diseases, 15(1) : 1-18.
Seaby EG .2020 .Ennis S. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies. Briefings in Functional Genomics, 19(4) : 243-258.
Hammerschmidt TG,Ribas G.,Saraiva-Pereira ML,Bonatto MP,Kessler RG .2018 .Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients. International Journal of Developmental Neuroscience, 66 : 18-23.
Walterfang M,Di Biase MA,Cropley VL,Scott AM,O'Keefe G,Velakoulis D,Pathmaraj K,Ackermann U .2020 .Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study. Neurology, 94(16) : e1716-e1725.
Eskes EC,Sjouke B,Vaz FM,Goorden SM,Van Kuilenburg AB .2020 .Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers. Molecular Genetics and Metabolism, 130(1) : 16-26.
Hammerschmidt TG,Encarnação M,Faverzani JL,de Fátima JL,de Oliveira FP .2023 .Molecular profile and peripheral markers of neurodegeneration in patients with Niemann-Pick type C: Decrease in Plasminogen Activator Inhibitor type 1 and Platelet-Derived Growth Factor type AA. Archives of Biochemistry and Biophysics, 735 : 109510.
Vujosevic S,Parra MM,Hartnett ME,O'Toole L,Nuzzi A,Limoli C,Villani E,Nucci P .2023 .Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children. Eye (Lond), 37(2) : 203-219.
Bolukbasi S,Dogan C,Kiykim E,Cakir A,Erden B .2019 .Multimodal imaging including optical coherence tomography angiography in patients with type B NiemannPick disease. International ophthalmology, 39 : 2545-2552.
Verheul C,Kleijn A .2018 .Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handbook of Clinical Neurology, 146 : 139-169.
Campbell K,Cawley NX,Luke R,Scott KE,Johnson N .2023 .Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. Biomarker Research, 11(1) : 14.
Agrawal N,Farhat NY,Sinaii N,Do AD,Xiao C .2023 .Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1. , 25(3) : 100349.
De Castro-Oros I,Irún P,Cebolla JJ,Rodriguez-Sureda V,Mallén M .2017 .Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study. Journal of Translational Medicine, 15(1) : 43.
Degtyareva AV,Proshlyakova TY,Gautier MS,Degtyarev DN,Kamenets EA .2019 .Oxysterol/chitotriosidase based selective screening for Niemann-Pick type C in infantile cholestasis syndrome patients. BMC Medical Genetics, 20(1) : 123.
Papandreou A,Doykov I,Spiewak J,Komarov N,Habermann S .2022 .Niemann-Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders. Developmental Medicine & Child Neurology, 64(12) : 1539-1546.
.2019 .Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of NiemannPick disease type C. Clinica Chimica Acta, (. , 494 : 58-63.
. .To read the copy of this license please visit: https://creativecommons. , : .